Hybio Pharmaceutical Market Cap

Hybio Pharmaceutical has a market cap or net worth of 15.42 billion as of March 9, 2026. Its market cap has increased by 43.00% in one year.

Market Cap

15.42B

Enterprise Value

17.23B

Revenue

898.10M

Ranking

n/a

PE Ratio

n/a

Stock Price

17.46

Market Cap Chart

Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 15.42B, an increase of 426.33%. That is a compound annual growth rate of 11.77%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	15.19B	-3.91%
Dec 31, 2025	15.81B	38.87%
Dec 31, 2024	11.38B	-5.08%
Dec 29, 2023	11.99B	-22.75%
Dec 30, 2022	15.53B	39.41%
Dec 31, 2021	11.14B	88.22%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Hepalink Pharmaceutical Group	15.29B
Guangdong Zhongsheng Pharmaceutical	15.31B
Zhejiang Jiuzhou Pharmaceutical	14.83B
Guobang Pharma	14.74B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	15.65B
Nanjing King-Friend Biochemical Pharmaceutical	15.66B
Shenzhen Kangtai Biological Products	15.73B
Shanghai Shyndec Pharmaceutical	14.52B

Market Cap Rankings